225 related articles for article (PubMed ID: 17920062)
41. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
Bramlett KS; Yao S; Burris TP
Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
[TBL] [Abstract][Full Text] [Related]
42. Insulin-dependent suppression of cholesterol 7α-hydroxylase is a possible link between glucose and cholesterol metabolisms.
Park WH; Pak YK
Exp Mol Med; 2011 Oct; 43(10):571-9. PubMed ID: 21817852
[TBL] [Abstract][Full Text] [Related]
43. Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms.
Cai SY; He H; Nguyen T; Mennone A; Boyer JL
J Lipid Res; 2010 Aug; 51(8):2265-74. PubMed ID: 20338915
[TBL] [Abstract][Full Text] [Related]
44. Augmenter of Liver Regeneration (ALR) regulates bile acid synthesis and attenuates bile acid-induced apoptosis via glycogen synthase kinase-3β (GSK-3β) inhibition.
Ibrahim S; Dayoub R; Saberi V; Buchner M; Melter M; Weiss TS
Exp Cell Res; 2020 Dec; 397(1):112343. PubMed ID: 33132196
[TBL] [Abstract][Full Text] [Related]
45. Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells.
Byun HW; Hong EM; Park SH; Koh DH; Choi MH; Jang HJ; Kae SH; Lee J
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):65-73. PubMed ID: 24463082
[TBL] [Abstract][Full Text] [Related]
46. Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility.
Xie Y; Blanc V; Kerr TA; Kennedy S; Luo J; Newberry EP; Davidson NO
J Biol Chem; 2009 Jun; 284(25):16860-16871. PubMed ID: 19386592
[TBL] [Abstract][Full Text] [Related]
47. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
Kaimori A; Potter JJ; Choti M; Ding Z; Mezey E; Koteish AA
Hepatology; 2010 Sep; 52(3):1033-45. PubMed ID: 20564330
[TBL] [Abstract][Full Text] [Related]
48. Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis.
Pandak WM; Schwarz C; Hylemon PB; Mallonee D; Valerie K; Heuman DM; Fisher RA; Redford K; Vlahcevic ZR
Am J Physiol Gastrointest Liver Physiol; 2001 Oct; 281(4):G878-89. PubMed ID: 11557507
[TBL] [Abstract][Full Text] [Related]
49. Prostaglandin E
Yan S; Tang J; Zhang Y; Wang Y; Zuo S; Shen Y; Zhang Q; Chen D; Yu Y; Wang K; Duan SZ; Yu Y
Hepatology; 2017 Mar; 65(3):999-1014. PubMed ID: 28039934
[TBL] [Abstract][Full Text] [Related]
50. Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo.
Kir S; Zhang Y; Gerard RD; Kliewer SA; Mangelsdorf DJ
J Biol Chem; 2012 Nov; 287(49):41334-41. PubMed ID: 23038264
[TBL] [Abstract][Full Text] [Related]
51. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
He H; Mennone A; Boyer JL; Cai SY
Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
[TBL] [Abstract][Full Text] [Related]
52. Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis.
Sanyal S; Båvner A; Haroniti A; Nilsson LM; Lundåsen T; Rehnmark S; Witt MR; Einarsson C; Talianidis I; Gustafsson JA; Treuter E
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15665-70. PubMed ID: 17895379
[TBL] [Abstract][Full Text] [Related]
53. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
[TBL] [Abstract][Full Text] [Related]
54. The antihypercholesterolemic effect of columbamine from Rhizoma Coptidis in HFHC-diet induced hamsters through HNF-4α/FTF-mediated CYP7A1 activation.
Wang Y; Han Y; Chai F; Xiang H; Huang T; Kou S; Han B; Gong X; Ye X
Fitoterapia; 2016 Dec; 115():111-121. PubMed ID: 27713083
[TBL] [Abstract][Full Text] [Related]
55. Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1.
Björkhem I; Araya Z; Rudling M; Angelin B; Einarsson C; Wikvall K
J Biol Chem; 2002 Jul; 277(30):26804-7. PubMed ID: 12011083
[TBL] [Abstract][Full Text] [Related]
56. Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-gamma coactivator 1alpha in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c.
Ponugoti B; Fang S; Kemper JK
Mol Endocrinol; 2007 Nov; 21(11):2698-712. PubMed ID: 17636037
[TBL] [Abstract][Full Text] [Related]
57. Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis.
Song Y; Xu C; Shao S; Liu J; Xing W; Xu J; Qin C; Li C; Hu B; Yi S; Xia X; Zhang H; Zhang X; Wang T; Pan W; Yu C; Wang Q; Lin X; Wang L; Gao L; Zhao J
J Hepatol; 2015 May; 62(5):1171-9. PubMed ID: 25533663
[TBL] [Abstract][Full Text] [Related]
58. A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
Luo J; Ko B; Elliott M; Zhou M; Lindhout DA; Phung V; To C; Learned RM; Tian H; DePaoli AM; Ling L
Sci Transl Med; 2014 Jul; 6(247):247ra100. PubMed ID: 25080475
[TBL] [Abstract][Full Text] [Related]
59. Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes.
Miao J; Choi SE; Seok SM; Yang L; Zuercher WJ; Xu Y; Willson TM; Xu HE; Kemper JK
Mol Endocrinol; 2011 Jul; 25(7):1159-69. PubMed ID: 21566081
[TBL] [Abstract][Full Text] [Related]
60. The pharmacological exploitation of cholesterol 7alpha-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol.
Gilardi F; Mitro N; Godio C; Scotti E; Caruso D; Crestani M; De Fabiani E
Pharmacol Ther; 2007 Dec; 116(3):449-72. PubMed ID: 17959250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
